Blister packing · Hot and humid markets

Blister packaging for hot and humid markets

In a blister, each tablet or capsule stays sealed until pressed out, and the film and lidding foil set the moisture barrier. WHO's long-term stability conditions for hot, humid markets are 30 °C/65 % RH (zone IVa) and 30 °C/75 % RH (zone IVb); regulators add their own rules. Each batch ships with a Certificate of Analysis and specification.

WHO conditionTemperature / relative humidityUsed for
Zone II25 °C ± 2 °C / 60 % RH ± 5 % RHLong-term stability testing for a zone II market
Zone IVa30 °C ± 2 °C / 65 % RH ± 5 % RHLong-term stability testing for a zone IVa market
Zone IVb30 °C ± 2 °C / 75 % RH ± 5 % RHLong-term stability testing for a zone IVb market
Accelerated (general case)40 °C ± 2 °C / 75 % RH ± 5 % RH, for 6 monthsA six-month test at higher heat and humidity

Conditions for zones II, IVa and IVb from WHO Technical Report Series No. 1010 (2018), Annex 10, a guideline written for medicines, which describes climatic zone IV as hot and humid.


Which climatic zone is my market in?

It is set by the country where the product will be sold, not where it is made: WHO's stability guideline ties the long-term condition to the climatic zone of the market the product is intended for.

Hot does not always mean zone IVb. In WHO's list of stability conditions by country (update of March 2021), Nigeria, Ghana, Cameroon and Tanzania are given a long-term condition of 30 °C/75 % RH, which corresponds to zone IVb. Saudi Arabia, the United Arab Emirates and Egypt are given 30 °C/65 % RH, which corresponds to zone IVa, and Lebanon 25 °C/60 % RH. Egypt's drug authority also places the country in zone IVa in its own stability guideline, and Ghana's Food and Drugs Authority names WHO zone IVb conditions in its guideline for supplements.

Read the list with its limits. It records the conditions WHO Member States require when a medicine is registered, so for a supplement it is a reference frame rather than law. WHO marks how each entry was obtained: those for Saudi Arabia, the UAE, Egypt and Lebanon come from regional harmonisation groups or official communications from national regulators; those for Nigeria, Ghana, Cameroon and Tanzania were collated at a conference of drug regulators in 2008; entries in square brackets are an industry association's estimates from climate maps, not statements by a regulator. The list gives conditions rather than zone names; the zone follows from WHO's note that zone IVa is 30 °C/65 % RH and zone IVb is 30 °C/75 % RH. We found no edition later than March 2021. Our country page lists 23 countries in the Gulf, the Levant and Africa, each with a note on how WHO obtained the entry.

The scheme runs from zone I to zone IVb; this page gives the conditions for zones II, IVa and IVb. The ICH stability guideline, Q1A(R2), addresses climatic zones I and II, and 30 °C/65 % RH appears in it both as a long-term option and as the intermediate condition. ICH left the conditions for zones III and IV to the regions and to WHO, and its regulators agreed that the stricter 30 °C/75 % RH is acceptable when an applicant chooses to use it.

Both documents are written for medicines. As far as we found, neither is binding on a food supplement by itself: one regulator writes stability conditions into its supplement guideline, another names none, as the regulator table further down shows.


Why does the pack decide how much humidity reaches the product?

Because zones IVa and IVb share the same 30 °C and differ only in humidity, and the pack sets how much of that humidity reaches a tablet or capsule.

WHO puts it in its own terms. Sensitivity to moisture, its guideline says, is not a concern for products in impermeable containers that give a permanent barrier to moisture, and studies of such products can be run at any controlled or ambient humidity. The same guideline says zone IVa data may be acceptable in place of zone IVb when humidity is not an issue, giving storage in glass containers as its example.

The label cannot make up for the pack. WHO states that a storage statement should not be used to compensate for inadequate or inferior packaging, and warns that testing at zone I or II conditions for a product supplied to zones III and IV could lead to substandard products.

The formula still counts: a product that readily takes up moisture asks more of its pack than one that does not. The pack, not the dose, decides how much of that humidity reaches the product, and in a blister the barrier comes from the film and the lidding foil.


How does a blister protect each dose?

Each tablet or capsule sits in its own cavity under the lidding foil, so pressing out one dose leaves the rest sealed.

In a bottle, every opening lets room air reach all the doses still inside. WHO's guidance for medicines uses a 500-tablet HDPE bottle as its example of a moisture-sensitive product in a large multidose container, and treats an in-use period of 30 days as normally acceptable without further supporting data.

Until a cavity is opened, how much moisture crosses its wall depends on the film. The figures below are water vapour transmission rates (WVTR) that film suppliers publish for flat film.

Film class (flat film)WVTR, g/m² per dayTest conditionWhere the figure comes from
PVC, uncoatedNo datasheet figure foundNot statedA film manufacturer presents it for low-barrier applications
PVC/PVDC, 40 g/m² PVDC coating0.6538 °C / 90 % RHBrochure of a PVDC supplier, 2018; values read from chart labels
PVC/PVDC, 60 g/m² PVDC coating0.538 °C / 90 % RHSame brochure
PVC/PVDC, 120 g/m² PVDC coating0.2238 °C / 90 % RHSame brochure
PCTFE film on its own, 76 µm0.023
0.062
30 °C / 65 % RH
40 °C / 75 % RH
Film datasheet, April 2026
Cold-form aluminium laminate (nylon/aluminium/polymer)Below 0.00138 °C / 90 % RHOne manufacturer's standard specification

Read the table with three limits in mind:

  • Compare rows only where the condition and the source match. The three PVC/PVDC rows share one source and 38 °C/90 % RH, so they can be read against each other as the effect of coating weight within that source. We do not have the thickness of the PVC base under these coatings, so the rows are not values for PVC/PVDC film in general. The PCTFE row is for PCTFE film on its own, measured at other conditions, and cannot be set beside them.
  • The values describe flat, unformed film. An article by an engineer at a packaging manufacturer notes that forming a cavity makes the laminate thinner, which can lower its barrier, and that the barrier of aluminium is independent of its thickness. In cold-formed aluminium blisters, the same article adds, a very small amount of water vapour may enter through the punched edge.
  • They are suppliers' figures, not measurements of blisters from our line.

If the same product is also sold in the EU, the PCTFE row raises one more question. Since 12 August 2026, Regulation (EU) 2025/40 has limited PFAS in food-contact packaging placed on the EU market. PCTFE is a fluorinated plastic. Whether a given PCTFE laminate meets that limit, and how the limit applies to it, are questions for a lawyer or the film supplier, so we do not present PVC/PCTFE on this page as a ready option.

Tablets and capsules are sealed on an Uhlmann B 1240, which forms the cavities, fills them, seals the lidding foil and cuts out each blister in one pass, and are then packed into printed cartons on an IMA IC 150. The Uhlmann B 1240 is built to run PVC, PVC/PVDC, PVC/PCTFE and cold-formed aluminium. That list shows what the machine is built for; it is not a statement of which films the plant holds.

The carton can be part of the pack too. WHO's guideline for medicines lets the secondary pack count as part of the container closure system in a stability study if it has protective properties and the labelling clearly tells the user to store the product in both the primary and the secondary pack, as in "store tablets in blisters in the provided cartons".


What does WHO say about aluminium blisters?

WHO's stability guideline lists aluminium/aluminium blisters for solid dosage forms among its examples of impermeable containers, meaning containers that give a permanent barrier to the passage of gases or solvents. For products in such containers, the same guideline allows stability studies at any controlled or ambient humidity.

Three limits come with it. The guideline is written for medicines, so a supplement regulator or an importer may still ask for data at its own condition. Aluminium is opaque, so the dose cannot be seen through the cavity. And cold-formed cavities are shallower than thermoformed ones: on the B 1240, forming depth is up to 24 mm for PVC (thermoforming), while cold-formed aluminium is shallower, which limits the size of dose a cavity can take.


When does a bottle with desiccant keep a product longer?

In at least one published case: a 2017 modelling study estimated a longer shelf life for one tablet in a bottle with desiccant than in an aluminium blister. Published in the trade journal Pharmaceutical Technology, it looked at one moisture-sensitive multivitamin tablet, containing 100 mg of thiamine, at 30 °C/75 % RH in four pack types, with the bottles modelled at 60 cc holding 30 tablets.

Pack in the modelEstimated shelf life at 30 °C/75 % RH
HDPE bottle with 2 g of silica gel2.6 years
Cold-formed aluminium/aluminium blister1.7 years
HDPE bottle without desiccant1.2 years
PVC blister0.5 years

The authors concluded that, for that tablet, the longest shelf life would not come from the impermeable aluminium blister. Read it with its limits: it is a calculation for one product at one condition, not a test; it appeared in a trade journal; and its figure is credited to a desiccant supplier. It is one worked case rather than a rule.

A blister is therefore not always the stronger pack. Which pack holds a product longer depends on the formula, the film and the pack size.


What do regulators in hot markets ask about the pack?

Each asks something different: of three documents we have read, Ghana's asks for stability data under WHO zone IVb conditions in the pack the product will be marketed in, Saudi Arabia's asks for a document on the packaging material of heat- or humidity-sensitive tablets and capsules, and Egypt's places the country in zone IVa.

Market and authorityDocumentWhat it asks about stability and the pack
Ghana, Food and Drugs AuthorityGuideline for Registration of Food/Nutritional/Dietary Supplements, FDA/HMD/GL-FS/2012/01, issued 1 March 2013 (the version published on the authority's website)Stability reports under WHO zone IVb conditions: accelerated testing at 40 °C ± 2 °C / 75 % RH ± 5 % RH for six months, and real-time testing to the end of the shelf life. The studies are done in the container closure system in which the product will be marketed in Ghana.
Saudi Arabia, Saudi Food and Drug Authority (food sector)Guide to Pre-registration Evaluation for Food Products (file uploaded July 2024)In its section on capsule-packed products, which lists tablets among them: for products affected by heat, humidity or sunlight and needing special storage, a document that describes the packaging material and verifies its safety for use. A stability study based on the shelf life the manufacturer proposes, with a maximum shelf life of five years. No test temperature or humidity is named.
Egypt, Egyptian Drug AuthorityStability testing guideline for pharmaceutical products, GL.CAPP.018, version 4, 10 November 2022Places Egypt in climatic zone IVa, 30 °C/65 % RH. Written for pharmaceutical products; whether the authority applies it to the supplements it registers is not confirmed in what we have read.

This is a reading of published documents, not legal advice and not a promise of registration. Registering the product in the country of sale is the brand owner's step, taken by the brand owner or a local applicant as each country requires. From us come the Certificate of Analysis and the specification with each batch, and copies of the plant's certificates on request.

For tablets and capsules, the same SFDA food guide also lists a Pharmaceutical GMP Certificate among the documents it asks for. The plant's GMP certification is for food supplements, under the Food Supplements Europe guide, not pharmaceutical GMP. Whether and how a registration file can meet that SFDA requirement is a question for your importer to settle.

The manufacturing group behind the plant already supplies many clients in Africa, and its main markets are the United Arab Emirates, Saudi Arabia and Lebanon.


What should I send with an enquiry for a hot market?

The product, the market where it will be sold, and anything your importer or regulator has already asked for.

Whatever the market, the same documents come with every order. Each batch ships with a Certificate of Analysis and its product specification. The plant is ISO 22000, GMP and HACCP certified and FDA registered; copies of the certificates with their numbers are sent to clients on request.


What your product decides

The format and size of the dose, how readily it takes up moisture, the market and the way it travels each change something about the pack. Each has its cost in time, run or risk.

Your productWhat changesWhat it costs you
Tablets or capsulesBoth are sealed in blisters on the B 1240 and packed in printed cartons; each dose stays closed until it is pressed outRun and time: a blister run starts from 2,000 cartons (at least 4,000 blisters), with production in 6 to 10 weeks
A large tablet or capsuleCavity depth sets what fits: up to 24 mm for PVC (thermoforming) on the B 1240; cold-formed aluminium is shallowerRisk: the dose may not fit an aluminium cavity. Send its dimensions with your enquiry
A formula that readily takes up moistureThe film and lidding foil set how much moisture reaches each dose; a bottle with desiccant is a different pack format, and in one published model it held one tablet longer than an aluminium blisterRisk: a barrier too low for the formula. Flat-film figures alone do not show how a product holds in its pack
A market whose supplement guideline asks for stability data in the marketed pack, as Ghana's doesGhana's guideline asks for the studies in the container closure system in which the product will be marketed in GhanaTime: the real-time part runs to the end of the shelf life
Heat- or humidity-sensitive tablets or capsules for Saudi ArabiaThe SFDA food guide asks for a document that describes the packaging material and verifies its safety for useOne more document in the registration file. Raise it before your importer files
A market whose regulator names a zone, as Egypt's names IVaStability data at that zone's condition, 30 °C/65 % RH for IVaRisk: Egypt's guideline is written for medicines. Confirm with your importer how it is applied to your product
Sea freight and storage in a hot countryThe pack meets heat on the way as well as in the marketRisk: heat in transit. In a 1992 study of sea shipments of medicines, temperatures inside the test packs reached 42.4 °C
A large pack used daily for weeksIn a bottle, each opening exposes the doses left; in a blister, unopened cavities stay sealed. WHO's guidance for medicines takes a 500-tablet bottle as its example of a large multidose container and treats 30 days in use as normally acceptable without further supporting dataTime: compare the days one pack is in use with that 30-day figure, and ask your regulator what it expects beyond it

Questions buyers ask about hot and humid markets

What is climatic zone IVb?

Zone IVb is the WHO climatic zone with a long-term stability condition of 30 °C ± 2 °C and 75 % RH ± 5 % RH; zone IVa uses 30 °C and 65 % RH. Both belong to climatic zone IV, which WHO Technical Report Series No. 1010, Annex 10 (2018), describes as hot and humid. WHO's general accelerated condition is 40 °C and 75 % RH for six months.

Is all of Africa or the Gulf in zone IVb?

No. In WHO's list of stability conditions by country (update of March 2021), Nigeria, Ghana, Cameroon and Tanzania are given 30 °C/75 % RH, which corresponds to zone IVb, but Saudi Arabia, the United Arab Emirates and Egypt are given 30 °C/65 % RH, which corresponds to zone IVa, and Lebanon 25 °C/60 % RH. The list was drawn up for medicines, so check what the regulator in your market asks for.

What does ICH say about hot climates?

ICH Q1A(R2) addresses climatic zones I and II, and 30 °C/65 % RH appears in it as a long-term option and as the intermediate condition. ICH left the conditions for zones III and IV to the regions and to WHO, and its regulators agreed that 30 °C/75 % RH is acceptable if an applicant chooses to use it. WHO's guideline uses 30 °C/65 % RH for zone IVa and 30 °C/75 % RH for zone IVb.

Does WHO count an aluminium blister as an impermeable container?

Yes. WHO's stability guideline lists aluminium/aluminium blisters for solid dosage forms among impermeable containers, and allows stability studies of products in such containers at any controlled or ambient humidity. The guideline is written for medicines, so a supplement regulator or an importer may still ask for data at its own condition.

Is a blister always better than a bottle in a humid market?

No. A 2017 modelling study of one vitamin tablet at 30 °C/75 % RH, published in a trade journal, estimated 2.6 years for a bottle with 2 g of silica gel, 1.7 years for a cold-formed aluminium/aluminium blister and 1.2 years for a bottle without desiccant. It is one calculated case, not a test. A blister keeps unopened doses sealed; which pack holds a product longer depends on the product.

Is a PVC blister enough for a hot and humid market?

Not necessarily. A film manufacturer presents plain PVC for low-barrier applications, and in the same 2017 model a PVC blister was estimated to hold that vitamin tablet for 0.5 years at 30 °C/75 % RH. Whether it is enough depends on how readily your product takes up moisture.

Does a regulator ask for the stability study in the pack I will sell?

Ghana's does. The 2013 supplement guideline published by its Food and Drugs Authority asks for stability studies under WHO zone IVb conditions, done in the container closure system in which the product will be marketed in Ghana.

What does Saudi Arabia ask about the packaging material?

The Saudi Food and Drug Authority's guide for food products, in its section on capsule-packed products, asks for tablet and capsule products affected by heat, humidity or sunlight that need special storage to come with a document describing the packaging material and verifying its safety for use. It also asks for a stability study based on the proposed shelf life, and caps shelf life at five years.

Which blister films can your machine run?

According to its machine documentation, the Uhlmann B 1240 that seals tablets and capsules is built to run PVC, PVC/PVDC, PVC/PCTFE and cold-formed aluminium. The list shows what the machine is built for; it is not a statement of which films the plant holds.

What shelf life do your products have?

24 months as standard, stated in the product documents. Stability data for a hot market are a separate matter, tied to a specific product in a specific pack at that market's condition.

Will you register my product in the importing country?

No. Registration in the country of sale is the brand owner's step, filed by the brand owner or a local applicant as that country requires. We supply the documents such a file usually draws on: the Certificate of Analysis and specification with each batch, and copies of the plant's certificates on request.

How hot does a pack get on the way to a hot market?

In a 1992 study of eleven essential medicines shipped from Copenhagen to Lagos, to Mombasa and on by road to Kampala, and to Bangkok, temperatures inside the test packs ranged from minus 3.5 °C to 42.4 °C and relative humidity from 20 % to 88 %. The study set out to measure conditions in sea shipments; it is old and about medicines, but it shows that the journey is part of the climate a pack goes through.


Read more

Climatic zones by country · Shelf life and storage · Manufacturing · Quality and certificates


Send an enquiry

Tell us the product, the market and what your importer has been asked for. We answer within 24 hours, Monday to Friday.

A ready-made formula starts from 100 units in stock packaging, with production from 2 weeks. Your own formula starts from 500 bottles per product, with production from 4 weeks. A blister run, with either kind of formula, starts from 2,000 cartons printed for your brand (at least 4,000 blisters), with production in 6 to 10 weeks. Each carton holds 1 to 4 blisters, and the lidding foil is printed for your brand as well.

Request a quote →


Sources

  • World Health Organization: WHO Technical Report Series No. 1010 (2018), Annex 10, Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. Climatic zone IV described as hot and humid (introduction); conditions by zone (2.2.7.1 and Appendix 3, Table A10.4, with the note that zone IVa may be acceptable in lieu of IVb); impermeable containers (glossary and 2.2.7.2); the secondary pack (2.2.4); storage statements (2.2.10); in-use stability (2.2.11). extranet.who.int. Checked 9 October 2026.
  • World Health Organization: Stability conditions for WHO Member States by Region, update of March 2021 (TRS 953, Annex 2, Appendix 1), with its notes on how each entry was obtained. who.int. Checked 9 October 2026.
  • ICH: Q1A(R2), Stability testing of new drug substances and products, Step 4 version of 6 February 2003; climatic zones I and II, long-term and intermediate conditions. database.ich.org. Checked 9 October 2026.
  • Food and Drugs Authority, Ghana: Guideline for Registration of Food/Nutritional/Dietary Supplements, FDA/HMD/GL-FS/2012/01, issued 1 March 2013, as published on the authority's website; stability under WHO zone IVb conditions in the container closure system in which the product will be marketed. fdaghana.gov.gh. Checked 9 October 2026.
  • Saudi Food and Drug Authority, Food Sector: Guide to Pre-registration Evaluation for Food Products, file uploaded July 2024; section on capsule-packed products, "Packing", stability study and maximum shelf life; Pharmaceutical GMP Certificate among the documents for tablets and capsules. sfda.gov.sa. Checked 9 October 2026.
  • Egyptian Drug Authority: stability testing guideline for pharmaceutical products, GL.CAPP.018, version 4, 10 November 2022. edaegypt.gov.eg. Checked 9 October 2026.
  • Logel, Rault, Emond, Waterman, Florez: Why Bottles with Desiccant Outperform Foil-Foil Blister Packaging, Pharmaceutical Technology, 1 September 2017, pp. s32-s34; a modelling study, figure credited to a desiccant supplier. pharmtech.com. Checked 9 October 2026.
  • Regulation (EU) 2025/40 on packaging and packaging waste, Article 5(5) on PFAS in food-contact packaging and Article 71 on application from 12 August 2026. eur-lex.europa.eu. Checked 9 October 2026.
Scroll to Top